PIRAMAL PHARMA
Back to Cashflow Statement
|
PIRAMAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,653 Cr | ₹892 Cr | ₹1,005 Cr | ₹484 Cr | ₹766 Cr |
What is the latest Cash Flow from Operating Activities ratio of PIRAMAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹1,653 Cr |
| Mar2025 | ₹892 Cr |
| Mar2024 | ₹1,005 Cr |
| Mar2023 | ₹484 Cr |
| Mar2022 | ₹766 Cr |
How is Cash Flow from Operating Activities of PIRAMAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,653 Cr | 85.21 | |
| Mar2025 | ₹892 Cr | -11.17 | |
| Mar2024 | ₹1,005 Cr | 107.60 | |
| Mar2023 | ₹484 Cr | -36.86 | |
| Mar2022 | ₹766 Cr | - | |
Compare Cash Flow from Operating Activities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹32,570.3 Cr | 2.5% | 25% | 23.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 2.5% |
25% |
23.2% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses